Correlation Between C4 TherapeuticsInc and Biomarin Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both C4 TherapeuticsInc and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 TherapeuticsInc and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between C4 TherapeuticsInc and Biomarin Pharmaceutical, you can compare the effects of market volatilities on C4 TherapeuticsInc and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 TherapeuticsInc with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 TherapeuticsInc and Biomarin Pharmaceutical.

Diversification Opportunities for C4 TherapeuticsInc and Biomarin Pharmaceutical

-0.36

Correlation Coefficient

C4 TherapeuticsInc  Biomarin Pharmaceutical

Very good diversification

The 3 months correlation between CCCC and Biomarin is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding C4 TherapeuticsInc and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and C4 TherapeuticsInc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 TherapeuticsInc are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of C4 TherapeuticsInc i.e., C4 TherapeuticsInc and Biomarin Pharmaceutical go up and down completely randomly.

Pair Corralation between C4 TherapeuticsInc and Biomarin Pharmaceutical

Given the investment horizon of 90 days C4 TherapeuticsInc is expected to under-perform the Biomarin Pharmaceutical. In addition to that, C4 TherapeuticsInc is 1.29 times more volatile than Biomarin Pharmaceutical. It trades about -0.35 of its total potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.13 per unit of volatility. If you would invest  8,710  in Biomarin Pharmaceutical on January 31, 2024 and sell it today you would lose (619.00) from holding Biomarin Pharmaceutical or give up 7.11% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

C4 TherapeuticsInc  vs.  Biomarin Pharmaceutical

C4 TherapeuticsInc

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in C4 TherapeuticsInc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting fundamental indicators, C4 TherapeuticsInc may actually be approaching a critical reversion point that can send shares even higher in May 2024.

Biomarin Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biomarin Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with C4 TherapeuticsInc and Biomarin Pharmaceutical

The main advantage of trading using opposite C4 TherapeuticsInc and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 TherapeuticsInc position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.

The idea behind C4 TherapeuticsInc and Biomarin Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.